<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60258">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02321514</url>
  </required_header>
  <id_info>
    <org_study_id>CS-03</org_study_id>
    <nct_id>NCT02321514</nct_id>
  </id_info>
  <brief_title>Early Feasibility Study of the Tendyne Mitral Valve System</brief_title>
  <official_title>Expanded Clinical Study of Tendyne Mitral Valve System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tendyne Holdings, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tendyne Holdings, LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to generate initial insights into the safety and performance of
      the Tendyne Mitral Valve System. The study includes adult patients with symptomatic mitral
      regurgitation who are not suitable candidates for conventional mitral valve repair or
      replacement. The study will include up to 110 subjects at up to 30 centers. Follow-up
      evaluations will be conducted through 2 years post implantation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety assessed by freedom from device or procedure related adverse events</measure>
    <time_frame>30-days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Performance assessed by freedom from device malfunction</measure>
    <time_frame>30-days</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Mitral Valve Regurgitation</condition>
  <arm_group>
    <arm_group_label>Tendyne Mitral Valve System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcatheter mitral valve replacement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tendyne Mitral Valve System</intervention_name>
    <description>Transcatheter mitral valve replacement</description>
    <arm_group_label>Tendyne Mitral Valve System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Severe mitral regurgitation of primary or secondary etiology

          2. NYHA functional Class â‰¥ II. If IV, patient must be ambulatory

          3. Heart team determines patient is not a suitable candidate for traditional surgical
             treatment

          4. Age 18 years or older

        Exclusion Criteria:

          1. Severe mitral calcification or mitral stenosis

          2. Chest condition that prevents transapical access

          3. Prior surgical or interventional treatment of mitral or aortic valves
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Daniel R. Mans</last_name>
    <phone>+16512895515</phone>
    <email>dmans@tendyne.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica L. Kleine</last_name>
    <phone>+16122800208</phone>
    <email>jkleine@tendyne.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>MedStar Washington Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petros Okubagzi</last_name>
      <email>Petros.G.Okubagzi@Medstar.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Wheeler</last_name>
      <email>lmwheeler@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Vasilis C Babaliaros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northshore University Health System</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Gegenhuber</last_name>
      <email>MGegenhuber@northshore.org</email>
    </contact>
    <investigator>
      <last_name>Mayra Guerrero</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raquel Pangilinan</last_name>
      <email>RPANGIL1@hfhs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Olson</last_name>
      <email>sara.olson@allina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Dettmer</last_name>
      <email>dettmem@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Heart &amp; Vascular Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Aston</last_name>
      <email>susan.aston@baylorhealth.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Grayburn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Flinders Medical Center</name>
      <address>
        <city>Bedford Park SA</city>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Collins</last_name>
      <email>Jane.Collins@sa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Ajay Sinhal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prince Charles Hospital</name>
      <address>
        <city>Chermside</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maricel Roxas</last_name>
      <email>maricel.roxas@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika O'Dea</last_name>
      <email>erika.odea@svha.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gro Sorensen</last_name>
      <email>gsorense@ous-hf.no</email>
    </contact>
    <investigator>
      <last_name>Gry Dahle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ShuFang Wang</last_name>
      <email>S.Wang@rbht.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Neil Moat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Norway</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 18, 2016</lastchanged_date>
  <firstreceived_date>December 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
